Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis

被引：1

作者：

Patel N. ^{[1
]}

Kumbhani D.J. ^{[1
]}

机构：

[1] Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, 75390-9047, TX

来源：

Current Heart Failure Reports | 2018年 / 15卷 / 5期

关键词：

Aortic stenosis; Heart failure; Serum biomarkers;

D O I：

10.1007/s11897-018-0403-y

中图分类号：

学科分类号：

摘要：

Purpose of Review: The purpose of this review is to outline the relationship between serum biomarkers of cardiac stress and the pathophysiologic progression of aortic stenosis, to identify studies exploring the utility of biomarkers in the risk stratification and management of patients with aortic stenosis, and to highlight the biomarkers most practical to management of patients with aortic stenosis. Recent Findings: Several biomarkers have been identified that reflect various aspects of the pathogenesis of calcific aortic stenosis, subsequent hemodynamic obstruction leading to myocardial remodeling, oxidative stress and injury, and concomitant systemic inflammation. These markers are associated with adverse outcomes in aortic stenosis and offer incremental value in risk prediction over traditional clinical assessment for aortic stenosis. NTproBNP and troponin are the most rigorously studied serum biomarkers in aortic stenosis, and only NTproBNP is currently reflected in any major guideline on aortic stenosis management. Summary: Serum biomarkers show promise in guiding management of aortic stenosis, but still require significant prospective investigation before they can be incorporated in major guidelines. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.

引用

页码：281 / 286

页数：5

共 41 条

[1]

Lindman B.R., Clavel M.A., Mathieu P., Et al., Calcific aortic stenosis, Nat Rev Dis Primers, 2, (2016)

[2]

Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Guyton R.A., O'Gara P.T., Ruiz C.E., Skubas N.J., Sorajja P., Sundt T.M., Thomas J.D., 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129, pp. 2440-2492, (2014)

[3]

Otto C.M., Kumbhani D.J., Alexander K.P., Calhoon J.H., Desai M.Y., Kaul S., Lee J.C., Ruiz C.E., Vassileva C.M., 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, 69, pp. 1313-1346, (2017)

[4]

Rosenhek R., Klaar U., Schemper M., Scholten C., Heger M., Gabriel H., Binder T., Maurer G., Baumgartner H., Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography, Eur Heart J, 25, pp. 199-205, (2004)

[5]

Otto C.M., Burwash I.G., Legget M.E., Munt B.I., Fujioka M., Healy N.L., Kraft C.D., Miyake-Hull C.Y., Schwaegler R.G., Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome, Circulation, 95, pp. 2262-2270, (1997)

[6]

Vahanian A., Et al., Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, 33, pp. 2451-2496, (2012)

[7]

Baumgartner H., Falk V., Bax J.J., de Bonis M., Hamm C., Holm P.J., Iung B., Lancellotti P., Lansac E., Rodriguez Munoz D., Rosenhek R., Sjogren J., Tornos Mas P., Vahanian A., Walther T., Wendler O., Windecker S., Zamorano J.L., Roffi M., Alfieri O., Agewall S., Ahlsson A., Barbato E., Bueno H., Collet J.P., Coman I.M., Czerny M., Delgado V., Fitzsimons D., Folliguet T., Gaemperli O., Habib G., Harringer W., Haude M., Hindricks G., Katus H.A., Knuuti J., Kolh P., Leclercq C., McDonagh T.A., Pi

[8]

Redfors B., Furer A., Lindman B.R., Burkhoff D., Marquis-Gravel G., Francese D.P., Ben-Yehuda O., Pibarot P., Gillam L.D., Leon M.B., Genereux P., Biomarkers in aortic stenosis: a systematic review, Structural Heart, 1, pp. 18-30, (2017)

[9]

Lindman B.R., Breyley J.G., Schilling J.D., Vatterott A.M., Zajarias A., Maniar H.S., Damiano R.J., Moon M.R., Lawton J.S., Gage B.F., Sintek M.A., Aquino A., Holley C.L., Patel N.M., Lawler C., Lasala J.M., Novak E., Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement, Heart, 101, pp. 1382-1388, (2015)

[10]

Steadman C.D., Ray S., Ng L.L., McCann G.P., Natriuretic peptides in common valvular heart disease, J Am Coll Cardiol, 55, pp. 2034-2048, (2010)

← 1 2 3 4 5 →